World journal of gastroenterology : WJG
-
World J. Gastroenterol. · Apr 2017
One year experience with computer-assisted propofol sedation for colonoscopy.
To report our one-year experience with computer assisted propofol sedation (CAPS) for colonoscopy as the first United States Medical Center to adopt CAPS technology for routine clinical use. ⋯ CAPS appears to be a safe, effective and efficient means of providing moderate sedation for colonoscopy in relatively healthy patients. Recovery times were much shorter than historical measures. There were few adverse events, and no serious adverse events, related to CAPS.
-
World J. Gastroenterol. · Apr 2017
Clinical TrialEffect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study.
To evaluate the ability of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 to colonize the intestinal environment of healthy subjects and modify the gut microbiota composition. ⋯ B. longum BB536 and L. rhamnosus HN001 showed the ability to modulate the gut microbiota composition, leading to a significant reduction of potentially harmful bacteria and an increase of beneficial ones. Further studies are needed to better understand the specific mechanisms involved in gut microbiota modulation.
-
To elucidate the epidemiological characteristics and associated risk factors of perforated peptic ulcer (PPU). ⋯ Elderly patients with comorbidities are associated with NSAIDs-associated PPU. Non-H. pylori, non-NSAID peptic ulcer is important etiology of PPU and alcohol consumption is associated risk factor.
-
World J. Gastroenterol. · Apr 2017
Predictors for difficult cecal insertion in colonoscopy: The impact of obesity indices.
To identify the factors influencing cecal insertion time (CIT) and to evaluate the effect of obesity indices on CIT. ⋯ Being female, having a lower or higher BMI than the normal range, a low VAT volume, and fellow involvement were predictors of a longer CIT.
-
World J. Gastroenterol. · Apr 2017
Observational StudySafety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis.
To evaluate the safety and efficacy of tenofovir disoproxil fumarate (TDF) as a first-line therapy in decompensated liver disease. ⋯ TDF therapy in decompensated cirrhosis patients was effective for decreasing HBV DNA levels and improving hepatic function with relatively lower CVR than in compensated cirrhosis. Thus, physicians should carefully monitor not only renal function but also treatment responses when using TDF in decompensated cirrhosis patients.